Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Ajanta Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
532331
INE031B01049
282.5572901
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
AJANTPHARM
43
36719.79
EPS(TTM)
Face Value(
)
Div & Yield %:
68.36
2
1.75
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
3971.12
3411.27
3140.64
2718.59
2196.42
1772.62
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3971.12
3411.27
3140.64
2718.59
2196.42
1772.62
Other Income
116.48
132.75
139.73
103.57
184.20
102.15
Stock Adjustments
22.17
21.99
56.60
74.60
-9.02
67.38
Total Income
4109.77
3566.01
3336.97
2896.76
2371.60
1942.15
EXPENDITURE :
Raw Materials
1101.59
1027.40
889.16
804.68
654.95
459.50
Power & Fuel Cost
66.44
65.53
54.09
43.42
38.56
33.77
Employee Cost
834.16
720.41
585.87
498.11
437.82
389.37
Other Manufacturing Expenses
168.11
185.50
169.95
119.25
124.80
121.50
Selling & Administrative Expenses
587.88
602.95
512.46
324.31
308.60
264.98
Miscellaneous Expenses
115.68
132.19
94.82
86.51
93.81
89.67
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2873.86
2733.98
2306.35
1876.28
1658.54
1358.79
Operating Profit
1235.91
832.03
1030.62
1020.48
713.06
583.36
Interest
6.80
5.23
9.12
6.90
9.10
0.41
Gross Profit
1229.11
826.80
1021.50
1013.58
703.96
582.95
Depreciation
132.16
126.95
120.96
111.49
91.29
69.90
Profit Before Tax
1096.95
699.85
900.54
902.09
612.67
513.05
Tax
280.56
141.08
171.17
216.68
168.09
108.66
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
9.15
0.05
9.51
9.77
3.45
12.63
Reported Net Profit
807.24
558.72
719.86
675.64
441.13
391.76
Extraordinary Items
11.11
12.87
-0.62
2.91
-2.89
-0.18
Adjusted Net Profit
796.13
545.85
720.48
672.73
444.02
391.94
Adjustment below Net Profit
-0.92
-74.72
-68.50
-32.42
-3.85
-0.99
P & L Balance brought forward
3089.29
2694.98
2125.83
1565.51
1244.15
932.97
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
642.17
89.69
82.21
82.90
115.93
79.59
P & L Balance carried down
3253.44
3089.29
2694.98
2125.83
1565.50
1244.15
Dividend
642.17
89.69
82.21
82.90
113.44
79.22
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
2550.00
350.00
475.00
475.00
650.00
450.00
Dividend Per Share(Rs)
51.00
7.00
9.50
9.50
13.00
9.00
Earnings Per Share-Unit Curr
63.89
44.22
83.85
77.70
50.30
44.67
Earnings Per Share(Adj)-Unit Curr
63.89
44.22
55.90
51.80
33.53
29.78
Book Value-Unit Curr
270.17
256.94
369.15
331.80
280.65
244.25
Book Value(Adj)-Unit Curr
270.17
256.94
246.10
221.20
187.10
162.83